Leadership

Dr. Dan Weng – President, CEO

Dr. Dan Weng serves as President and Chief Executive Officer of the company. Dr. Weng has extensive experience in managing and growing CRO businesses, including nearly six years at EPS International Holding Co., a subsidiary of EPSH, where he was Chairman, President and CEO. More …

Brad Phillips – Vice President, Clinical Operations

Brad Phillips has over twenty years of oncology-related experience and thirteen years of CRO experience as a project manager. As Vice President of Clinical Operations, Brad oversees all project management and clinical monitoring for Medelis. More …

Dr. Inder Makin – Vice President, Devices & Radiological Health

Dr. Inder Makin has more than 20 years of experience developing healthcare technologies including medical devices, ultrasound, radio frequency, lasers, magnetic resonance and computer tomography. More …

Dr. Peter F. Lenehan – Vice President, Medical Affairs (Consultant)

Dr. Lenehan is a uniquely qualified physician-scientist and senior executive with broad experience in clinical and academic oncology, molecular biology, anti-cancer targeted pharmaceutical drug development, cardiovascular biotechnology, and laboratory research. More…


Tell Us About Your Study

Relationships are important to us. Reach out to learn more about how our approach, experience, investigator relationships, bid transparency and flexibility deliver success for our clients.

Connect